WSW, NY, 15th December 2025, FinanceWire … Read More
VOO
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR)
WSW, NY, 12th December 2025, FinanceWire … Read More
Inspira Technologies May be Perfectly Positioned as Flu Cases Increase and Respiratory Complexity Grows (NASDAQ: IINN)
WSW, NY, 11th December 2025, FinanceWire … Read More
Alpha Tau Medical Just Treated Its First Brain Tumor Patient – and It Could Mark an Inflection Point for the Company (NASDAQ: DRTS)
WSW, NY, 10th December 2025, FinanceWire … Read More
PolyPid Clears a Key FDA Milestone, Reducing Regulatory Risk Ahead of Its Planned NDA Filing (NASDAQ: PYPD)
WSW, NY, 5th December 2025, FinanceWire … Read More
DarioHealth is Gaining Strong Momentum as GLP-1 Costs Reshape Employer Health Strategy (NASDAQ: DRIO)
WSW, NY, 5th December 2025, FinanceWire … Read More
Duke Robotics is Positioning Its Technology to Meet America’s Emerging Grid Security Demands (OTCQB: DUKR)
WSW, NY, 4th December 2025, FinanceWire … Read More
BiomX Is Targeting the Infection Threat Returning to Modern War – And the Military Is Paying Attention (NYSE: PHGE)
WSW, NY, 4th December 2025, FinanceWire … Read More
Silexion Therapeutics Advances Toward a Late-Stage Phase 2/3 Trial in Pancreatic Cancer With Strong Regulatory Momentum (NASDAQ: SLXN)
WSW, NY, 2nd December 2025, FinanceWire … Read More
Entera Bio Is Building More Than a GLP-1 Story – It’s Advancing the First Oral Anabolic for a 200M-Patient Disease (NASDAQ: ENTX)
WSW, NY, 1st December 2025, FinanceWire … Read More